Valuation: Yunnan Botanee Bio-Technology Group Co.LTD

Capitalization 20.44B 2.81B 2.66B 2.47B 2.2B 3.97B 239B 4.35B 30.67B 11.32B 97.96B 10.57B 10.33B 425B P/E ratio 2024 *
28.9x
P/E ratio 2025 * 19.3x
Enterprise value 18.05B 2.48B 2.35B 2.18B 1.94B 3.51B 211B 3.84B 27.08B 10B 86.51B 9.33B 9.13B 375B EV / Sales 2024 *
2.75x
EV / Sales 2025 * 2.34x
Free-Float
-
Yield 2024 *
1.11%
Yield 2025 * 1.73%
More valuation ratios * Estimated data
Dynamic Chart
Yunnan Botanee Bio-Technology's Parent, Shareholder to Divest Stake Nov. 11 MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2024 Oct. 24 CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023. Aug. 30 CI
Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback announced on August 30, 2023 has closed with 3,649,618 shares, representing 0.87% for CNY 234.72 million. Aug. 29 CI
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2024 Aug. 27 CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023. Jul. 01 CI
Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold Apr. 29 MT
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 Apr. 25 CI
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Full Year Ended December 31, 2023 Apr. 25 CI
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023. Apr. 01 CI
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024. Mar. 24 CI
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD Mar. 14 CI
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd. Mar. 12 CI
More news
1 day-1.28%
1 week-3.07%
Current month-1.22%
1 month-13.37%
3 months+18.75%
6 months-6.82%
Current year-28.63%
More quotes
1 week
48.12
Extreme 48.12
49.57
1 month
46.88
Extreme 46.88
56.58
Current year
39.30
Extreme 39.3
74.00
1 year
39.30
Extreme 39.3
74.00
3 years
39.30
Extreme 39.3
227.00
5 years
39.30
Extreme 39.3
289.35
10 years
39.30
Extreme 39.3
289.35
More quotes
Director TitleAgeSince
Chief Executive Officer 61 2016-11-30
Director of Finance/CFO 42 2016-11-30
Corporate Officer/Principal 45 2012-06-30
Manager TitleAgeSince
Chairman 61 2014-05-31
Director/Board Member 56 2013-09-30
Director/Board Member 48 2012-10-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.28%-3.07%-28.47%-76.92%2.81B
-0.63%+5.43%-21.71%-17.47%198B
+0.52%+0.11% - - 24.09B
-1.01%-1.01%+12.77%+8.95%20.41B
+3.95%+5.99%-26.64%-58.24%7.16B
+1.84%+1.31%-33.30%-23.49%6.74B
-1.83%-3.33%-12.11%-14.76%4.91B
-3.21%-3.68%-20.65%-43.94%4.3B
+0.67%-1.82%+4.26%+44.50%4.4B
-1.09%+4.33%-10.98%-22.47%3.33B
Average -0.21%-0.04%-15.20%-22.65% 27.61B
Weighted average by Cap. -0.43%+3.46%-18.64%-16.69%
See all sector performances

Financials

2024 *2025 *
Net sales 6.57B 904M 855M 793M 707M 1.28B 76.71B 1.4B 9.85B 3.64B 31.48B 3.4B 3.32B 137B 7.55B 1.04B 983M 911M 813M 1.47B 88.21B 1.61B 11.33B 4.18B 36.19B 3.9B 3.82B 157B
Net income 713M 98.12M 92.74M 86.03M 76.72M 139M 8.33B 152M 1.07B 395M 3.42B 368M 360M 14.82B 1.07B 147M 139M 129M 115M 208M 12.48B 228M 1.6B 592M 5.12B 552M 540M 22.21B
Net Debt -2.39B -329M -311M -288M -257M -464M -27.9B -509M -3.58B -1.32B -11.45B -1.23B -1.21B -49.67B -2.8B -386M -365M -338M -302M -545M -32.74B -597M -4.21B -1.55B -13.44B -1.45B -1.42B -58.28B
More financial data * Estimated data
Logo Yunnan Botanee Bio-Technology Group Co.LTD
Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.
Employees
3,852
More about the company
Date Price Change Volume
24-12-09 49.61 ¥ +1.97% 14,868,820
24-12-09 48.65 ¥ -1.28% 3,481,629
24-12-06 49.28 ¥ +1.50% 3,892,937
24-12-05 48.55 ¥ -0.04% 2,756,682
24-12-04 48.57 ¥ -2.10% 3,474,498

End-of-day quote Shenzhen S.E., December 08, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart YUNNAN-BOTANEE-BIO-TECHNOMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
48.65CNY
Average target price
62.40CNY
Spread / Average Target
+28.26%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300957 Stock